Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-1,919
Closed -$334K – 264
2023
Q3
$334K Hold
1,919
– – 0.04% 203
2023
Q2
$330K Buy
1,919
+120
+7% +$20.7K 0.05% 187
2023
Q1
$299K Hold
1,799
– – 0.05% 192
2022
Q4
$264K Sell
1,799
-10
-0.6% -$1.48K 0.05% 201
2022
Q3
$268K Buy
1,809
+36
+2% +$6.02K 0.07% 198
2022
Q2
$305K Hold
1,773
– – 0.09% 178
2022
Q1
$334K Hold
1,773
– – 0.08% 179
2021
Q4
$433K Buy
+1,773
New +$388K 0.11% 159

Other funds holding ZTS

CGN Advisors's ZTS Position: Q4 2023 in Review

CGN Advisors sold out of Zoetis (ZTS) in Q4 2023, closing a stake of 1,919 shares — an estimated $334K sold.

CGN Advisors first reported a position in ZTS in Q4 2021 and held it in 8 quarters. The position peaked at $433K in Q4 2021. 1,747 funds tracked by Wall St. Rank hold ZTS as of Q4 2023.

  • CGN Advisors reported no remaining Zoetis position as of Q4 2023 after selling out during the quarter.
  • CGN Advisors sold 1,919 Zoetis shares in Q4 2023, an estimated $334K.
  • CGN Advisors first reported a position in Zoetis in Q4 2021 and held it in 8 quarters.
  • CGN Advisors's Zoetis position peaked at $433K in Q4 2021.
  • 1,747 funds tracked by Wall St. Rank held Zoetis as of Q4 2023.

Based on CGN Advisors's 13F filing for Q4 2023, filed 5 Jan 2024.